{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T03:57:08Z","timestamp":1780372628180,"version":"3.54.1"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,7,15]],"date-time":"2019-07-15T00:00:00Z","timestamp":1563148800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,7,15]],"date-time":"2019-07-15T00:00:00Z","timestamp":1563148800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arthritis Res Ther"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s13075-019-1956-1","type":"journal-article","created":{"date-parts":[[2019,7,15]],"date-time":"2019-07-15T14:08:54Z","timestamp":1563199734000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Distinct biomarkers for different bones in osteoporosis with rheumatoid arthritis"],"prefix":"10.1186","volume":"21","author":[{"given":"T.","family":"Tomizawa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1827-382X","authenticated-orcid":false,"given":"H.","family":"Ito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Murata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Hashimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Murakami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Nishitani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Azukizawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Okahata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Doi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Saito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Furu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Hamaguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Mimori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Matsuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,7,15]]},"reference":[{"key":"1956_CR1","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1038\/nrendo.2014.125","volume":"10","author":"SE Sattui","year":"2014","unstructured":"Sattui SE, Saag KG. Fracture mortality: associations with epidemiology and osteoporosis treatment. Nat Rev Endocrinol. 2014;10:592\u2013602. \n                    https:\/\/doi.org\/10.1038\/nrendo.2014.125\n                    \n                  .","journal-title":"Nat Rev Endocrinol"},{"key":"1956_CR2","volume-title":"Osteoporosis and osteopenia in the distal forearm predict all-cause mortality independent of grip strength: 22-year follow-up in the population-based Troms\u00f8 study","author":"AV Hauger","year":"2018","unstructured":"Hauger AV. Osteoporosis and osteopenia in the distal forearm predict all-cause mortality independent of grip strength: 22-year follow-up in the population-based Troms\u00f8 study; 2018."},{"key":"1956_CR3","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1007\/s00296-016-3453-z","volume":"36","author":"D Kim","year":"2016","unstructured":"Kim D, Cho SK, Choi CB, et al. Incidence and risk factors of fractures in patients with rheumatoid arthritis: an Asian prospective cohort study. Rheumatol Int. 2016;36:1205\u201314. \n                    https:\/\/doi.org\/10.1007\/s00296-016-3453-z\n                    \n                  .","journal-title":"Rheumatol Int"},{"key":"1956_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1136\/rmdopen-2018-000671","volume":"4","author":"R Mazzucchelli","year":"2018","unstructured":"Mazzucchelli R, P\u00e9rez Fernandez E, Cresp\u00ed-Villar\u00edas N, et al. Trends in hip fracture in patients with rheumatoid arthritis: results from the Spanish National Inpatient Registry over a 17-year period (1999-2015). TREND-AR study. RMD Open. 2018;4:1\u20139. \n                    https:\/\/doi.org\/10.1136\/rmdopen-2018-000671\n                    \n                  .","journal-title":"RMD Open"},{"key":"1956_CR5","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1007\/s00198-018-4473-1","volume":"29","author":"S Jin","year":"2018","unstructured":"Jin S, Hsieh E, Peng L, et al. Incidence of fractures among patients with rheumatoid arthritis: a systematic review and meta-analysis. Osteoporos Int. 2018;29:1263\u201375. \n                    https:\/\/doi.org\/10.1007\/s00198-018-4473-1\n                    \n                  .","journal-title":"Osteoporos Int"},{"issue":"6","key":"1956_CR6","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1302\/0301-620X.91B6.22346","volume":"91-B","author":"J. Wilson","year":"2009","unstructured":"Wilson J, Bonner TJ, Head M, et al. Variation in bone mineral density by anatomical site in patients with proximal humeral fractures:772\u20135. \n                    https:\/\/doi.org\/10.1302\/0301-620X.91B6.22346\n                    \n                  .","journal-title":"The Journal of Bone and Joint Surgery. British volume"},{"key":"1956_CR7","doi-asserted-by":"publisher","first-page":"373","DOI":"10.3109\/14397595.2015.1004276","volume":"25","author":"O Ishida","year":"2015","unstructured":"Ishida O, Furuya T, Inoue E, et al. Risk factors for established vertebral fractures in Japanese patients with rheumatoid arthritis: results from a large prospective observational cohort study. Mod Rheumatol. 2015;25:373\u20138. \n                    https:\/\/doi.org\/10.3109\/14397595.2015.1004276\n                    \n                  .","journal-title":"Mod Rheumatol"},{"key":"1956_CR8","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1007\/s00198-012-2080-0","volume":"24","author":"T Furuya","year":"2013","unstructured":"Furuya T, Inoue E, Hosoi T, et al. Risk factors associated with the occurrence of hip fracture in Japanese patients with rheumatoid arthritis: a prospective observational cohort study. Osteoporos Int. 2013;24:1257\u201365. \n                    https:\/\/doi.org\/10.1007\/s00198-012-2080-0\n                    \n                  .","journal-title":"Osteoporos Int"},{"key":"1956_CR9","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1007\/s10067-013-2415-z","volume":"33","author":"K Ochi","year":"2014","unstructured":"Ochi K, Go Y, Furuya T, et al. Risk factors associated with the occurrence of distal radius fractures in Japanese patients with rheumatoid arthritis: a prospective observational cohort study. Clin Rheumatol. 2014;33:477\u201383. \n                    https:\/\/doi.org\/10.1007\/s10067-013-2415-z\n                    \n                  .","journal-title":"Clin Rheumatol"},{"key":"1956_CR10","doi-asserted-by":"publisher","unstructured":"Ochi K, Furuya T, Ikari K, et al. Sites, frequencies, and causes of self-reported fractures in 9,720 rheumatoid arthritis patients: a large prospective observational cohort study in Japan. Arch Osteoporos. 2013;8. \n                    https:\/\/doi.org\/10.1007\/s11657-013-0130-7\n                    \n                  .","DOI":"10.1007\/s11657-013-0130-7"},{"key":"1956_CR11","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1007\/s00198-010-1501-1","volume":"22","author":"S Vasikaran","year":"2011","unstructured":"Vasikaran S, Eastell R, Bruy\u00e8re O, et al. Markers of bone turnover for the prediction of fracture risk and monitoring of osteoporosis treatment: a need for international reference standards. Osteoporos Int. 2011;22:391\u2013420. \n                    https:\/\/doi.org\/10.1007\/s00198-010-1501-1\n                    \n                  .","journal-title":"Osteoporos Int"},{"key":"1956_CR12","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1002\/acr.23440","volume":"70","author":"KD Wysham","year":"2018","unstructured":"Wysham KD, Shoback DM, Imboden JB, Katz PP. Association of high anti\u2013cyclic citrullinated peptide seropositivity and lean mass index with low bone mineral density in rheumatoid arthritis. Arthritis Care Res. 2018;70:961\u20139. \n                    https:\/\/doi.org\/10.1002\/acr.23440\n                    \n                  .","journal-title":"Arthritis Care Res"},{"key":"1956_CR13","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1002\/1529-0131(200003)43:3<522::AID-ANR7>3.0.CO;2-Y","volume":"43","author":"G Haugeberg","year":"2000","unstructured":"Haugeberg G, Uhlig T, Falch JA, et al. Bone mineral density and frequency of osteoporosis in female patients with rheumatoid arthritis: results from 394 patients in the Oslo County rheumatoid arthritis register. Arthritis Rheum. 2000;43:522\u201330. \n                    https:\/\/doi.org\/10.1002\/1529-0131(200003)43:3<522::AID-ANR7>3.0.CO;2-Y\n                    \n                  .","journal-title":"Arthritis Rheum"},{"key":"1956_CR14","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1136\/ard.2008.091264","volume":"68","author":"J Kalvesten","year":"2008","unstructured":"Kalvesten J, Haugeberg G, Elden A, et al. Adalimumab therapy reduces hand bone loss in early rheumatoid arthritis: explorative analyses from the PREMIER study. Ann Rheum Dis. 2008;68:1171\u20136. \n                    https:\/\/doi.org\/10.1136\/ard.2008.091264\n                    \n                  .","journal-title":"Ann Rheum Dis"},{"key":"1956_CR15","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1007\/s00223-018-0401-9","volume":"102","author":"AM Dubrovsky","year":"2018","unstructured":"Dubrovsky AM, Lim MJ, Lane NE. Osteoporosis in rheumatic diseases: anti-rheumatic drugs and the skeleton. Calcif Tissue Int. 2018;102:607\u201318. \n                    https:\/\/doi.org\/10.1007\/s00223-018-0401-9\n                    \n                  .","journal-title":"Calcif Tissue Int"},{"issue":"2","key":"1956_CR16","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1007\/s00198-015-3256-1","volume":"27","author":"T. Iwata","year":"2015","unstructured":"Iwata T, Ito H, Furu M, et al. Periarticular osteoporosis of the forearm correlated with joint destruction and functional impairment in patients with rheumatoid arthritis. 691\u2013701. 2016. \n                    https:\/\/doi.org\/10.1007\/s00198-015-3256-1\n                    \n                  .","journal-title":"Osteoporosis International"},{"key":"1956_CR17","doi-asserted-by":"publisher","unstructured":"Nakagami Y, Sugihara G, Takei N, et al. Effect of physical state on pain mediated through emotional health in rheumatoid arthritis. Arthritis Care Res (Hoboken) 0\u20132. 2018. \n                    https:\/\/doi.org\/10.1002\/acr.23779\n                    \n                  .","DOI":"10.1002\/acr.23779"},{"issue":"3","key":"1956_CR18","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1002\/1529-0131(200003)43:3<495::AID-ANR4>3.0.CO;2-U","volume":"43","author":"John T. Sharp","year":"2000","unstructured":"Sharp JT, Strand V, Leung HOI, et al. Treatment with leflunomide slows radiographic progression of rheumatoid arthritis results from three randomized controlled trials of leflunomide in patients with active rheumatoid arthritis. Arthritis Rheum. 2000;43:495\u2013505.","journal-title":"Arthritis & Rheumatism"},{"issue":"6","key":"1956_CR19","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1136\/ard.2003.010983","volume":"63","author":"D van der Heijde","year":"2004","unstructured":"Report C. Long term evaluation of radiographic disease progression in a subset of patients with rheumatoid arthritis treated with leflunomide beyond 2 years. 2004:737\u20139. \n                    https:\/\/doi.org\/10.1136\/ard.2003.010983\n                    \n                  .","journal-title":"Annals of the Rheumatic Diseases"},{"issue":"2","key":"1956_CR20","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1007\/s00198-005-2019-9","volume":"17","author":"E. M. C. Lau","year":"2005","unstructured":"Orwoll HL\u00c6E, Cauley \u00c6SC\u00c6J. The determinants of bone mineral density in Chinese men\u2014results from Mr. Os ( Hong Kong ), the first cohort study on osteoporosis in Asian men. 2019:297\u2013303. \n                    https:\/\/doi.org\/10.1007\/s00198-005-2019-9\n                    \n                  .","journal-title":"Osteoporosis International"},{"issue":"9","key":"1956_CR21","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1007\/s001980070056","volume":"11","author":"K. Nakamura","year":"2000","unstructured":"Nakamura K, Tanaka Y, Saitou K, et al. Age and sex difference in the bone mineral density of the forearm based on health check-up data of 6343 Japanese. Osteoporos Int 2000;11:772\u20137. \n                    https:\/\/doi.org\/10.1007\/s001980070056\n                    \n                  .","journal-title":"Osteoporosis International"},{"key":"1956_CR22","doi-asserted-by":"publisher","first-page":"1558","DOI":"10.1007\/s00198-005-1871-y","volume":"16","author":"LJ Melton","year":"2005","unstructured":"Melton LJ, Looker AC, Shepherd JA, et al. Osteoporosis assessment by whole body region vs. site-specific DXA. Osteoporos Int. 2005;16:1558\u201364. \n                    https:\/\/doi.org\/10.1007\/s00198-005-1871-y\n                    \n                  .","journal-title":"Osteoporos Int"},{"key":"1956_CR23","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1186\/2193-1801-2-331","volume":"2","author":"K Ohnaru","year":"2013","unstructured":"Ohnaru K, Sone T, Tanaka K, et al. Hip structural analysis: a comparison of DXA with CT in postmenopausal Japanese women. Springerplus. 2013;2:331. \n                    https:\/\/doi.org\/10.1186\/2193-1801-2-331\n                    \n                  .","journal-title":"Springerplus"},{"key":"1956_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00223-001-1054-6","volume":"70","author":"J Iwamoto","year":"2002","unstructured":"Iwamoto J, Takeda T, Ichimura S. Forearm bone mineral density in postmenopausal women with rheumatoid arthritis. Calcif Tissue Int. 2002;70:1\u20138. \n                    https:\/\/doi.org\/10.1007\/s00223-001-1054-6\n                    \n                  .","journal-title":"Calcif Tissue Int"},{"key":"1956_CR25","doi-asserted-by":"publisher","first-page":"2109","DOI":"10.1007\/s00198-016-3506-x","volume":"27","author":"JT Lloyd","year":"2016","unstructured":"Lloyd JT, Alley DE, Hochberg MC, et al. Changes in bone mineral density over time by body mass index in the health ABC study. Osteoporos Int. 2016;27:2109\u201316. \n                    https:\/\/doi.org\/10.1007\/s00198-016-3506-x\n                    \n                  .","journal-title":"Osteoporos Int"},{"key":"1956_CR26","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1016\/S8756-3282(02)00728-7","volume":"30","author":"JA Clowes","year":"2002","unstructured":"Clowes JA, Hannon RA, Yap TS, et al. Effect of feeding on bone turnover markers and its impact on biological variability of measurements. Bone. 2002;30:886\u201390. \n                    https:\/\/doi.org\/10.1016\/S8756-3282(02)00728-7\n                    \n                  .","journal-title":"Bone"},{"key":"1956_CR27","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/0378-5122(95)00968-X","volume":"23","author":"K Hill","year":"1996","unstructured":"Hill K. The demography of menopause. Maturitas. 1996;23:113\u201327. \n                    https:\/\/doi.org\/10.1016\/0378-5122(95)00968-X\n                    \n                  .","journal-title":"Maturitas"},{"issue":"1","key":"1956_CR28","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1007\/s00223-010-9418-4","volume":"88","author":"Ana Paula de Souza Faloni","year":"2010","unstructured":"Paula A, Faloni DS, Schoenmaker T. Jaw and long bone marrows have a different osteoclastogenic potential. 2011:63\u201374. \n                    https:\/\/doi.org\/10.1007\/s00223-010-9418-4\n                    \n                  .","journal-title":"Calcified Tissue International"},{"key":"1956_CR29","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/s00223-013-9727-5","volume":"93","author":"M Feh\u00e9rv\u00e1ri","year":"2013","unstructured":"Feh\u00e9rv\u00e1ri M, Sarkadi H, Krepuska M, et al. Bone mineral density is associated with site-specific atherosclerosis in patients with severe peripheral artery disease. Calcif Tissue Int. 2013;93:55\u201361. \n                    https:\/\/doi.org\/10.1007\/s00223-013-9727-5\n                    \n                  .","journal-title":"Calcif Tissue Int"},{"issue":"5","key":"1956_CR30","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1007\/s00198-019-04864-4","volume":"30","author":"K. S. Bezerra de Carvalho","year":"2019","unstructured":"Bezerra de Carvalho KS, Vasco RFV, Custodio MR, et al. Chronic kidney disease is associated with low BMD at the hip but not at the spine. Osteoporos Int. 2019. \n                    https:\/\/doi.org\/10.1007\/s00198-019-04864-4\n                    \n                  .","journal-title":"Osteoporosis International"},{"key":"1956_CR31","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.bone.2018.06.009","volume":"114","author":"J Behera","year":"2018","unstructured":"Behera J, George AK, Voor MJ, et al. Hydrogen sulfide epigenetically mitigates bone loss through OPG\/RANKL regulation during hyperhomocysteinemia in mice. Bone. 2018;114:90\u2013108. \n                    https:\/\/doi.org\/10.1016\/j.bone.2018.06.009\n                    \n                  .","journal-title":"Bone"},{"key":"1956_CR32","doi-asserted-by":"publisher","first-page":"2176","DOI":"10.3390\/nu7042176","volume":"7","author":"V Fratoni","year":"2015","unstructured":"Fratoni V, Brandi ML. B vitamins, homocysteine and bone health. Nutrients. 2015;7:2176\u201392. \n                    https:\/\/doi.org\/10.3390\/nu7042176\n                    \n                  .","journal-title":"Nutrients"},{"key":"1956_CR33","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1111\/j.1572-0241.2007.01170.x","volume":"102","author":"L Peyrin-Biroulet","year":"2007","unstructured":"Peyrin-Biroulet L, Rodriguez-Gu\u00e9ant RM, Chamaillard M, et al. Vascular and cellular stress in inflammatory bowel disease: revisiting the role of homocysteine. Am J Gastroenterol. 2007;102:1108\u201315. \n                    https:\/\/doi.org\/10.1111\/j.1572-0241.2007.01170.x\n                    \n                  .","journal-title":"Am J Gastroenterol"},{"key":"1956_CR34","first-page":"355","volume":"40","author":"E Bahtiri","year":"2015","unstructured":"Bahtiri E, Bahtiri E, Islami H, et al. Relationship of homocysteine levels with lumbar spine and femur neck BMD in postmenopausal women relationship of homocysteine levels with lumbar spine and femur neck BMD in postmenopausal women. Acta Reumatol Port. 2015;40:355\u201362.","journal-title":"Acta Reumatol Port"},{"key":"1956_CR35","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/j.bone.2008.10.051","volume":"44","author":"M Herrmann","year":"2008","unstructured":"Herrmann M, Garcia P, Tami A, et al. Hyperhomocysteinemia induces a tissue specific accumulation of homocysteine in bone by collagen binding and adversely affects bone. Bone. 2008;44:467\u201375. \n                    https:\/\/doi.org\/10.1016\/j.bone.2008.10.051\n                    \n                  .","journal-title":"Bone"},{"key":"1956_CR36","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1080\/03009740801998812","volume":"37","author":"C Ozer","year":"2008","unstructured":"Ozer C, Guler H, Turhanoglu AD, et al. The relationship between anti-cyclic citrullinated peptide and bone mineral density and radiographic damage in patients with rheumatoid arthritis. Scand J Rheumatol. 2008;37:337\u201342. \n                    https:\/\/doi.org\/10.1080\/03009740801998812\n                    \n                  .","journal-title":"Scand J Rheumatol"},{"key":"1956_CR37","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1136\/ard.2007.073718","volume":"67","author":"R Gerli","year":"2007","unstructured":"Gerli R, Bocci EB, Sherer Y, et al. Association of anti-cyclic citrullinated peptide antibodies with subclinical atherosclerosis in patients with rheumatoid arthritis. Ann Rheum Dis. 2007;67:724\u20135. \n                    https:\/\/doi.org\/10.1136\/ard.2007.073718\n                    \n                  .","journal-title":"Ann Rheum Dis"},{"key":"1956_CR38","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1159\/000330806","volume":"196","author":"P Gradin","year":"2012","unstructured":"Gradin P, Hollberg K, Cassady AI, et al. Transgenic overexpression of tartrate-resistant acid phosphatase is associated with induction of osteoblast gene expression and increased cortical bone mineral content and density. Cells Tissues Organs. 2012;196:68\u201381. \n                    https:\/\/doi.org\/10.1159\/000330806\n                    \n                  .","journal-title":"Cells Tissues Organs"},{"key":"1956_CR39","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1359\/jbmr.080329","volume":"23","author":"AJ Janckila","year":"2008","unstructured":"Janckila AJ, Neustadt DH, Yam LT. Significance of serum TRACP in rheumatoid arthritis. J Bone Miner Res. 2008;23:1287\u201395. \n                    https:\/\/doi.org\/10.1359\/jbmr.080329\n                    \n                  .","journal-title":"J Bone Miner Res"},{"key":"1956_CR40","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1111\/j.1601-0825.2010.01772.x","volume":"17","author":"E Golub","year":"2010","unstructured":"Golub E, Qing L, Wen D, et al. Anatomic site variability in rat skeletal uptake and desorption of fluorescently labeled bisphosphonate. Oral Dis. 2010;17:427\u201332. \n                    https:\/\/doi.org\/10.1111\/j.1601-0825.2010.01772.x\n                    \n                  .","journal-title":"Oral Dis"},{"key":"1956_CR41","doi-asserted-by":"publisher","first-page":"2729","DOI":"10.1007\/s00198-014-2817-z","volume":"25","author":"MA Paggiosi","year":"2014","unstructured":"Paggiosi MA, Peel N, Mccloskey E, Walsh JS. Comparison of the effects of three oral bisphosphonate therapies on the peripheral skeleton in postmenopausal osteoporosis : the TRIO study. Osteoporos Int. 2014;25:2729\u201341. \n                    https:\/\/doi.org\/10.1007\/s00198-014-2817-z\n                    \n                  .","journal-title":"Osteoporos Int"},{"issue":"9","key":"1956_CR42","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1136\/ard.44.9.580","volume":"44","author":"P N Sambrook","year":"1985","unstructured":"Sambrook PN, Ansell BM, Foster S, et al (1985) Bone turnover in early rheumatoid arthritis. 2. Longitudinal bone density studies. Ann Rheum Dis 44:580\u2013584. doi: \n                    https:\/\/doi.org\/10.1136\/ard.44.9.580\n                    \n                  .","journal-title":"Annals of the Rheumatic Diseases"},{"key":"1956_CR43","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1007\/s001980070106","volume":"11","author":"FE Alenfeld","year":"2000","unstructured":"Alenfeld FE, Diessel E, Brezger M, et al. Detailed analyses of periarticular osteoporosis in rheumatoid arthritis. Osteoporos Int. 2000;11:400\u20137. \n                    https:\/\/doi.org\/10.1007\/s001980070106\n                    \n                  .","journal-title":"Osteoporos Int"},{"key":"1956_CR44","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1038\/nrrheum.2012.153","volume":"8","author":"G Schett","year":"2012","unstructured":"Schett G, Gravallese E. Bone erosion in rheumatoid arthritis: mechanisms, diagnosis and treatment. Nat Rev Rheumatol. 2012;8:656\u201364. \n                    https:\/\/doi.org\/10.1038\/nrrheum.2012.153\n                    \n                  .","journal-title":"Nat Rev Rheumatol"}],"container-title":["Arthritis Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-019-1956-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13075-019-1956-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-019-1956-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,13]],"date-time":"2020-07-13T23:25:42Z","timestamp":1594682742000},"score":1,"resource":{"primary":{"URL":"https:\/\/arthritis-research.biomedcentral.com\/articles\/10.1186\/s13075-019-1956-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,15]]},"references-count":44,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["1956"],"URL":"https:\/\/doi.org\/10.1186\/s13075-019-1956-1","relation":{},"ISSN":["1478-6362"],"issn-type":[{"value":"1478-6362","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7,15]]},"assertion":[{"value":"19 April 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 July 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was conducted according to the principles of the Declaration of Helsinki and was approved by the Ethics Committee of Kyoto University before the start of the study (E1308).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"We received no expense or support specific to this study. However, there exist some competing interests. The Department of Advanced Medicine for Rheumatic Diseases is supported by Nagahama City, Shiga, Japan, and four pharmaceutical companies (Mitsubishi Tanabe Pharma Co., Chugai Pharmaceutical Co. Ltd., UCB Japan Co. Ltd., and AYUMI Pharmaceutical Co.). KURAMA cohort study is supported by grant from Daiichi Sankyo Co. Ltd. HI has received a research grant and\/or speaker fee from Bristol-Myers, Astellas, Kyocera, and Asahi-Kasei. MH has received a research grants from Astellas and Bristol-Myers. MT has received research grants from Astellas, Abbvie, Eisai, Pfizer, Takeda, and Taisho-Toyama. TT, KN, KM, MA, AO, KD, MH, TM, and SM declare that they have no competing interests. This study is conducted as an investigator-initiated study. The sponsors were not involved in the study design; in the collection, analysis, interpretation of the data; in the writing of this manuscript; or in the decision to submit the article for publication. The authors, their immediate families, and any research foundations with which they are affiliated have not received any financial payments or other benefits from any commercial entity related to the subject of this article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"174"}}